Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

FabOvar

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A monoclonal antibody fragment. The asset is used for the treatment and prevention of ovarian carcinoma.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Business Products and Services
Other Industries
Therapeutic Devices
Primary Office
  • Via Santa Lucia, 6
  • 20122 Milan
  • Italy

FabOvar Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore FabOvar‘s full profile, request access.

Request full access to PitchBook

FabOvar Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore FabOvar‘s full profile, request access.

Request full access to PitchBook